Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2008
11/19/2008EP1349545B1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
11/19/2008EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/19/2008EP1320357B1 Topical polymeric antimicrobial emulsion
11/19/2008EP1307226B1 Vitronectin receptor antagonist pharmaceuticals
11/19/2008EP1274462B1 Targeted transfection of cells using a biotinylated dendrimer
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008CN101310011A Ex-vivo application of solid microparticulate therapeutic agents
11/19/2008CN101309746A Method for production of single- and multi-layer microcapsules
11/19/2008CN101309707A Compositions comprising lipoxygenase inhibitors and cyclodextrin
11/19/2008CN101309706A Controlled drug release composition and drug releasing medical device
11/19/2008CN101309679A 胶冻组合物 Jelly composition
11/19/2008CN101309672A Intraorally rapidly disintegrating tablet
11/19/2008CN101307317A Method for preparing rabies virus antigen
11/19/2008CN101307123A Temperature-induced gelatinizing-in-situ triblock copolymer, preparation method and applications
11/19/2008CN101307088A Method for preparing cholic acid conjugates
11/19/2008CN101306203A Hydrophilic polymer-boxwood extract conjugate and its medicine composition
11/19/2008CN101306202A Ginkgo flavone and lactone -cyclodextrin derivate inclusion complex and preparation method thereof
11/19/2008CN101306201A Antihypertensive medicine carrier and combination medicine
11/19/2008CN101306197A Administration system of plasminogen activator sustained and controlled release preparation, construction and use thereof
11/19/2008CN101306196A Biodegradable nano-particles bonded with hemoglobin and production method thereof
11/19/2008CN101306195A Recombination human soluble tumor necrosis factor related apoptosis inducing ligand freeze dried protection agents and preparation method thereof
11/19/2008CN101306182A Elemene vein emulsion injection and preparation method thereof
11/19/2008CN101306181A Elemene fat emulsion injection and preparation method thereof
11/19/2008CN101306176A Traditional Chinese medicine paste, its preparation method and use
11/19/2008CN101306159A Siberian solomonseal rhizome polysaccharide buccal tablets
11/19/2008CN101306134A Compound Nanxing pain paste and cataplasm combination and its preparation method
11/19/2008CN101306107A Chinese traditional medicine composition for preventing and treating intestinal parasitical diseases of aquatic animal>
11/19/2008CN101306103A Medicine composition containing morinda root oligosacchride and its preparation method
11/19/2008CN101306092A Veterinary herbal medicine for treating poultry kidney abscess
11/19/2008CN101306072A Gadol buccal tablet and its preparation method
11/19/2008CN101306029A Hydroxypropyl¿Cbelta-cyclodextrin inclusion compound of Chinese angelica volatile oil, its preparation method and use
11/19/2008CN101306025A Hydroxypropyl¿Cbelta-cyclodextrin inclusion compound of brucea fruit volatile oil, its preparation method and use
11/19/2008CN101306019A Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method
11/19/2008CN101305996A Compound domperidone dimethicone dispersible tablet and its preparation method
11/19/2008CN101305995A Sustained release preparation containing domperidone pantoprazole sodium and its preparation method
11/19/2008CN101305994A Minimizing adverse experience associated with oxybutynin therapy
11/19/2008CN101305992A Compound sustained-released injection containing neonatal blood vessel restraining agent
11/19/2008CN101305991A Compound sustained-released injection containing neonatal blood vessel restraining agent
11/19/2008CN101305989A Yibosu capsule and its preparation method
11/19/2008CN101305988A Compound alendronate sodium vitamine D3 orally disintegrating tablets and preparation method thereof
11/19/2008CN101305987A Compound gabapentin mecobalamin dispersible tables and preparation method thereof
11/19/2008CN101305986A Lafutidine Tablet and its preparation method
11/19/2008CN101305985A Preparation method of coffee acid polylactic acid copolymer nanometer microsphere
11/19/2008CN101305984A Medicaments solution
11/19/2008CN101305983A Nanometer Ag antibiotic gent for women and its preparation method
11/19/2008CN101305982A 局部凝胶给药体系 Topical gel delivery system
11/19/2008CN100434462C Thin film contg. starch
11/19/2008CN100434456C Method of preparing polymer nanometerl micron ball assisted by ultrasonic wave
11/19/2008CN100434120C Amphipathic fluorescence target nano micelle and its preparation method
11/19/2008CN100434117C Suppository for treating chronic cervicitis
11/18/2008US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy
11/18/2008US7452965 nine amino acid, disulfide-constrained peptide that selectively bound and was internalized into colon cancer cells; exhibit decreased or a substantially nonexistent immunogenicity in an in vivo system
11/18/2008US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus
11/18/2008US7452864 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media
11/18/2008US7452860 Zinc-free and low-zinc insulin preparations having improved stability
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452680 MCT1 transporters expressed in blood brain barrier cells
11/18/2008US7452551 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
11/18/2008US7452549 A source of delta-tocotrienol and/or-tocopherol acts synergistically with an antioxidant source comprising polyphenols, to effect suppression of LDL oxidation in serum. The combination of these two antioxidant sources has
11/18/2008US7452543 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
11/18/2008US7452541 Hapten-carrier conjugates and uses thereof
11/18/2008US7452533 Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol
11/18/2008US7452530 Administering a blocking agent of tumor necrosis factors or receptors; treatment of Sin Nombre (SNV), Ebola, Marburg, Lassa, and Dengue viral disease
11/18/2008CA2588106A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof
11/18/2008CA2469369C Compositions containing both sedative and non-sedative antihistamines
11/18/2008CA2440399C Epitope testing using hla
11/18/2008CA2439500C Drug delivery system for hydrophobic drugs
11/18/2008CA2434682C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
11/18/2008CA2416147C Dermal application system for aminolevulinic acid
11/18/2008CA2415840C Pharmaceutical pellets comprising tamsulosin and a process for making the same
11/18/2008CA2406846C Pharmacotherapeutic process and composition for central nervous system disorders
11/18/2008CA2405097C Coloured ophthalmic product
11/18/2008CA2402652C Viscoelastics for use in middle ear surgery
11/18/2008CA2397537C External plaster containing 4-biphenylyl acetic acid
11/18/2008CA2381219C Monomeric protein of the tgf-beta family
11/18/2008CA2379511C A process for stabilizing antioxidant compounds, and aqueous compositions
11/18/2008CA2376202C Novel preparation and administration form comprising an acid-labile active compound
11/18/2008CA2368625C Solubilizing aids in powder form for solid pharmaceutical presentation forms
11/18/2008CA2359640C Topical sprays
11/18/2008CA2359338C Bacillus subtilis takemi and use thereof
11/18/2008CA2358054C Cyanocobalamin (vitamin b12) treatment in allergic disease
11/18/2008CA2352430C New pharmaceutical composition and the process for its preparation
11/18/2008CA2343284C Topical application products
11/18/2008CA2343116C Methods and compositions for increasing intestinal absorption of fats
11/18/2008CA2342587C Long term drug-sustained release preparation
11/18/2008CA2341614C Prolonged storage of red blood cells
11/18/2008CA2341366C Micronised pharmaceutical compositions
11/18/2008CA2340417C Methods for forming regional tissue adherent barriers and drug delivery systems
11/18/2008CA2339190C Compressed compositions comprising clarified xanthan gum
11/18/2008CA2334146C Radioiodinated phenols for brachytherapy
11/18/2008CA2333442C Spray composition
11/18/2008CA2326809C Solid, quick dissolving cetirizine formulations
11/18/2008CA2316539C Sustained-release pharmaceutical composition
11/18/2008CA2301646C Pharmaceutical suspension comprising nevirapine hemihydrate
11/18/2008CA2298349C Antiallergic composition and antipruritic composition
11/18/2008CA2281614C Monomers derived from hydroxy acids and polymers prepared therefrom
11/18/2008CA2281420C Preparation of pharmaceutically-active granules
11/18/2008CA2265444C Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
11/18/2008CA2263924C Improved methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator
11/18/2008CA2259764C Pharmaceutical compositions containing mupirocin